The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.
Source link
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Date:
More like thisRelated
U.S. ordering some government staff to depart Saudi Arabia as concerns about Houthis flare
The U.S. State Department has...
Balloon Fiesta brings in 900,000+ visitors for 2026 event
Digital Assignment EditorBalloon Fiesta saw a lot of traffic...
Highest-Selling Country Music Artists: Morgan Wallen Is No. 1
Morgan Wallen isn’t just breaking records — he’s rewriting...
Mattel Adds Board Member As Activist Investor Pressure Mounts
Mattel named an executive from one of its largest...